These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11838277)

  • 1. Microbiological and pharmaco-toxicological profile of nifuratel and its favourable risk/benefit ratio for the treatment of vulvo-vaginal infections. A review.
    Mendling W; Mailland F
    Arzneimittelforschung; 2002; 52(1):8-13. PubMed ID: 11838277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of nifuratel in vulvovaginal infections. A meta-analysis of metronidazole-controlled trials.
    Mendling W; Poli A; Magnani P
    Arzneimittelforschung; 2002; 52(10):725-30. PubMed ID: 12442634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections.
    Polatti F; Nappi RE; Brundu B; Fantuzzi M; Frisenda L
    Arzneimittelforschung; 2003; 53(10):730-7. PubMed ID: 14650366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statement of the Polish Gynecological Society Expert Group on the use of Macmiror Complex 500].
    Polish Gynecological Society Expert Group
    Ginekol Pol; 2012 Dec; 83(12):956-9. PubMed ID: 23488303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections.
    Della Casa V; Noll H; Gonser S; Grob P; Graf F; Pohlig G
    Arzneimittelforschung; 2002; 52(9):699-705. PubMed ID: 12404886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local combined therapy of vaginal infections by nifuratel-nistatin].
    Jahić M; Balić A; Nurkić M; Dragović J; Adzajlić A; Habibović A; Mesalić L; Zigić A
    Med Glas (Zenica); 2010 Feb; 7(1):86-8. PubMed ID: 20387731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of candidal urinary tract infection with nifuratel.
    Grüneberg RN; Leakey A
    Br Med J; 1976 Oct; 2(6041):908-10. PubMed ID: 974657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Macmiror, Macmiror Complex--combined antimicrobial preparation for the treatment of vulvo-vaginal infection].
    Akush Ginekol (Sofiia); 2008; 47(2):55. PubMed ID: 18642589
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis?
    Togni G; Battini V; Bulgheroni A; Mailland F; Caserini M; Mendling W
    Antimicrob Agents Chemother; 2011 May; 55(5):2490-2. PubMed ID: 21321147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial activity of nifuratel].
    Dubini F; Furneri P
    G Ital Chemioter; 1985; 32(3):545-52. PubMed ID: 3879754
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative activity of clotrimazole and nifuratel plus nystatin in vaginal infections of various etiologies].
    Nencioni T; Tuveri E; Olgiati ML; Faravelli M; Salvini P
    Minerva Ginecol; 1984; 36(7-8):465-9. PubMed ID: 6493579
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilogical and toxicological properties of econazole, a broad-spectrum antimycotic.
    Thienpont D; Van Cutsem J; Van Nueten JM; Niemegeers CJ; Marsboom R
    Arzneimittelforschung; 1975 Feb; 25(2):224-30. PubMed ID: 1173036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A multicenter study of the antimicrobial effect of Macmiror and Macmiror Complex in the treatment of vaginal infections].
    Karag'ozov I; Shopova E; Poriazov K; Abaliev I; Kozovski I; Ianeva R; Drenska S; Vasileva P; Bozhinova S; Popov I; Stoĭkov S
    Akush Ginekol (Sofiia); 1999; 38(3):61-2. PubMed ID: 10734688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of vaginal infections with Macmiror and Macmiror Complex].
    Zlatkov V; Karag'ozov I
    Akush Ginekol (Sofiia); 1998; 37(2):57-9. PubMed ID: 9859542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of five nitrofurans.
    Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1978; 24(3):161-5. PubMed ID: 657876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal and antibacterial activities of pentacycloundecane tetra-amines.
    Onajole OK; Coovadia Y; Govender T; Kruger HG; Maguire GE; Naidu D; Singh N; Govender P
    Chem Biol Drug Des; 2011 Apr; 77(4):295-9. PubMed ID: 21241455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A complex antibiotic preparation obtained from a medicinal plant from the family Asteraceae].
    Smirnov VV; Bondarenko AS; Petrenko GT; Prikhod'ko VA; Evseenko OV; Pavlenko LV
    Mikrobiol Z; 1995; 57(4):73-82. PubMed ID: 8548074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of the antibacterial and antifungal activity of oxine and its derivatives.
    Khan KA; Khan SA; Khalid SM; Ahmed A; Siddiqui BS; Saleem R; Siddiqui S; Faizi S
    Arzneimittelforschung; 1994 Aug; 44(8):972-5. PubMed ID: 7945545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.